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Summary.-Pretreatment of rats bytherepeated administration ofcertain alkylating
carcinogens has been shown to stimulate the removal of06-alkylguanine fromhepatic
DNA. Prolonged feeding with the aromatic amide 2-acetylaminofluorene has a
similar effect. In this report, aflatoxin B1, an agent from another chemically distinct
class of carcinogen, is shown to be capable of stimulating the repair of 06-methyl-
guanine in hepatic DNA. The sensitivity of this system is shown by the fact that
this repair response can be fully stimulated as early as 1 day after treatment with a
single dose.
IT IS NOW RECOGNIZED that in some
regions of the world where food-spoilage
by fuingi is a problem, aflatoxins formed
by the mould Aspergillus flavus can lead
to prolonged human exposure and may be
hepatocarcinogenic (Wogan, 1976). The
question arises whether their presence
might alter the response to other factors,
and in this connection it is important to
evaluate the possible role of additional
carcinogenic components in the environ-
ment. The following studies on the repair
of 06-methylguanine reveal an interesting
effect that could be relevant to the action
of another important group of environ-
mental carcinogens, the nitroso com-
pounds. In view of the current debate on
the potential importance of the roles of
different environmental carcinogens (i.e.
those associated with lifestyle or occupa-
tion, Anon., 1981), observations of the
kind made in this communication may be
of interest.
Reports have already indicated that the
chronic treatment of rats with dimethyl-
phenyltriazene (DMPT, Cooper et al.,
1978), dimethylnitrosamine (DMN, Mon-
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tesano et al., 1979) or diethylnitrosamine
(DEN, Margison et al., 1979) can lead to an
enhanced repair of 06-alkylguanine in
hepatic DNA, and that prolonged treat-
ment with 2-acetylaminofluorene (AAF)
willproduce a similar effect (Buckley et al.,
1979). As the two classes of carcinogen
used in these pretreatments are very dif-
ferent in chemical structure, it was impor-
tant to determine whether agents from
other chemically distinct classes of car-
cinogen are capable of inducing a similar
response. These results show that chemi-
cally unrelated compounds (i.e. nitros-
amines, an aromatic amide and a fungal
product, aflatoxin), which are known to be
hepatoxic but activated by different
mechanisms, are all capable of enhancing
the repair of 06-methylguanine.
MATERIALS AND METHODS
Materials.-Di[14C]-methylamine hydro-
chloride (54 mCi/mmol) was obtained from
the Radiochemical Centre, Amersham, Bucks,
and used to prepare di-[14C]methylnitros-
amine (14C-DMN) by the method of Dutton
& Heath (1956); unlabelled nitrosamine was
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supplied by Eastman Kodak Ltd, Kirkby,
Lancs. Aflatoxin B1 (AFB1) was purchased
from Sigma Chemical Co., London, and
Sephadex GIO was from Pharmacia (G.B.)
Ltd. Wistar rats of the strain maintained in
these laboratories were used.
Methods. -Male rats (220-240 g) were
given i.p. itijections of AFB1, suspended in a
solution of gum acacia (1.75% in saline);
control animals received vehicle alone. At
various times later they were given i.p.
injections of 14C-DMN (2 mg/kg; sp. act.
3-8 mCi/mmol) prepared in saline. After 5 h
theanimals werekilled, andtheliverremoved.
In each case a small sample of tissue was
fixed in formalin, embedded in paraffin, sec-
tioned, and stained with haematoxylin and
eosin. The remainder was frozen on to dry ice
and stored at -30°C for isolation of DNA.
DNA was extracted by a modified phenol
procedure (Kirby & Cook, 1967) and hydro-
lysed in 0-IM HCI (70°C, 30 min). Authentic
marker compounds 7-methylguanine, 3-
methyladenine and 06-methylguanine were
added and the pH ofthe hydrolysate adjusted
to 2-95. Purine bases were separated by
chromatography (Lawley & Shah, 1972;
Margison et al., 1976) on columns of 1 x 100cm
Sephadex G-10 eluted with 0-05M ammonium
formate-0.02% (w/v) sodium azide (pH 6.75)
at a flow rate of 15-20 ml/h. The absorption
at 260 nm ofeach fraction (4.5 ml) was deter-
mined, from which the amounts of adenine
and guanine were calculated. The samples
were dried and counted for radioactivity after
addition of water (0-5 ml) and Triton-toluene
phosphor (5 ml). These measurements were
used to estimate the amounts of methylated
purines, on the assumption that the specific
activity ofthe 14C-labelled methyl group had
remained unchanged.
RESULTS
Effect ofsingle doses
In the first of these experiments
(Table I) rats were treated with AFB1
at doses which span the half LD50
range for the rat (IARC, 1976). Twenty-
four hours later these animals were chal-
lenged with a low dose (2 mg/kg) of
14C-DMN, and after 5 h the amounts of
methylpurines formed in hepatic DNA
were measured. There was no obvious
effect of the pretreatment upon the rate
of metabolism of DMN, as the amounts of
N7-methylguanine present were similar
for all pretreatment doses, but changes
were detected in the amounts of 06_
methylguanine and 3-methyladenine in
DNA. At a pretreatment dose of 2 mg/kg,
there was a clearenhancement oftherepair
of 06-methylguanine, which is indicated
by ratios of 06-methylguanine to 7-
methylguanine, that are less than the
TABLE I. Amounts of methylpurines in liver DNA of Wistar rats treated with varying
doses ofAFB1, 24 h before administration of 14C-DMN (2 mg/kg). Each analyses was
made on DNA from the liver of an individual animal killed 5 h after injection of the
nitrosamine. The figures in parentheses are the amounts of 06-methylguanine (06-meG)
or of 3-methyladenine (3-meA) relative to 7-methylguanine (7-meG)
AFB1 06-meG
(mg/kg) (,mol/mol
0 48-4 (0-081)
45-0 (0-072)
0-5 43-3 (0-061)
60-9 (0-077)
2-0 28-1 (0-037)
24-0 (0-031)
6-0 67-2 (0.089)
59-1 (0-106)
12-0 75-3 (0-115)
67-2 (0-095)
3-meA 7-meG d/min/ d/min/
parent base) ,imol A* ,mol G*
18-3 (0.030)
19-1 (0-031)
23-5 (0 033)
26-1 (0 033)
22-1 (0-029)
22-8 (0-030)
37-9 (0-050)
29-0 (0-052)
40-5 (0.062)
33-6 (0-047)
600-6
622-9
706-1
792-8
760-2
771-3
751-3
556-2
651-7
708-7
2-8
11-2
13-5
15-0
40-7
77-9
36-6
12-1
12-1
27-1
4-6
13-3
15-9
14-5
50-7
105-9
65-6
16-9
12-1
31-5
* These values are corrected for differences in the specific radioactivity of the 14C-DMN by dividing the
actual value by the specific activity of the batch of isotope used.
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TABLE II.-Changes in amounts ofmethyl purines in liver DNA of Wistar rats pretreated
with AFB1 (2 mg/kg) and then given 14C-DMN (2 mg/kg) at different times later.
(a) At the appropriate interval after pretreatment with AFB1 or vehicle, animals were
given an i.p. injection of labelled nitrosamine. 5 h later they were killed, liver DNA was
isolated and analysed as described in Methods. Each group comprised 2 animals
except in the case of 1-day controls (3 rats) and 28-day pretreated (1 rat). Values shown
are the mean of separate analyses on liver DNA of individual animals. DMN injected
on basis of body weight+ when pretreated with AFB1; A-+when injected with 14C-DMN.
(b) Details as above except that in each case a single dose of unlabelled DMN (2 mg/kg)
was administered 3 days after the AFB1 treatment
Condition
(a) Single dose ofDMN
Control 6 ht-
12 h+
1 day+
10 day++
21 day++
28 day++
35 day++
Pretreated 6 h+
12 h+
1 day+
2 day+
5 day+
10 day+
10 day++
15 day++
21 day++
28 day++
35 day++
(b) Two doses ofDMN
Pretreated Day 10++
Day 18++
Day 21++
06-meG N7-meG
(,tmol/mol guanine)
56-2
52-3
47-1
70-1
71-7
60-4
65-2
77-9
71-4
26-1
27-9
34-5
56-0
39-7
33-5
25-6
46-7
45-3
735-1
559.0
616-5
673-3
659-6
646-9
736-9
770-0
702-5
765-8
952-5
885-1
930 5
593-7
496-8
523-7
610-0
724-0
d/min/ d/min/
06/N7 ,umol A* /zmol G*
0-076
0093
0-076
0-104
0-109
0-093
0-089
0-101
0-102
0 034
0-031
0-039
0-060
0-067
0-067
0049
0077
0-063
5-6
13-9
7-5
13-6
14-3
8-4
14-1
4-9
3-3
59-3
83-1
171-8
195-1
43-8
19-4
20-5
44-8
24-4
5-3
12-4
9-2
8-8
12-4
8-3
12-8
8-9
2-4
78-3
82-0
159-6
264-8
34-7
24-0
19-4
59-2
12-6
20-2 504-6 0-040 132-1 121-2
39 0 507-8 0-078 24-9 24-2
36-8 557-7 0-066 69-5 42-3
* Values corrected as in Table T.
expected value (0.11) for this alkylating
agent (O'Connor et al., 1979). Below this
(at 0 5 mg/kg) there was no effect, and
above 2 mg/kg the toxic effects of AFB1
may have been responsible for inhibiting
the repair process. These higher doses (6
and 12 mg/kg) also inhibited the repair of
3-methyladenine, as determined from a
comparison of the ratios of 3-methyl-
adenine to 7-methylguanine, but at the
lower doses, and in the experiments
reported later, there was no change in this
repair function: the methylpurine ratio
remained constant at 0 03 + 0-0015.
The toxicity of the mycotoxin was also
clear from the histological appearance of
the liver, slight degeneration could be
detected even at the lower doses, and,
above 2 mg/kg, both degeneration and
some necroses were present. In keeping
with this, there was some evidence ofa
regenerative response, as judged by the
incorporation into DNA of labelled 1-C
fragments from the breakdown of 14C_
DMN. This was increased by pretreatment
with AFB1 at doses of 2 mg/kg and above
(Table I).
Duration of the repair response
Although environmental exposures to
aflatoxins are often protracted, it was of
interest to see how long the enhanced
capacity for the repair of 06-methyl-
guanine could persist after a single treat-
ment. In these experiments rats were pre-
treated with AFB1 (2 mg/kg) and chal-
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TABLE III. Changes in amount of methyl purines in liver DANA of Wfiistar rats pretreated
with AFB1 (0.5 mg/kg) and then given 14C-DMN (2 mg/kg) at different times later.
The DMN dose was based on the body weight on the day of the nitros8amine injection.
Each group comprised 2 rats and the values showvn are the mean of analyses for the in-
dividual animals
Conditions
Control 1 clay
10 days
Pr'etreatedl 1 (lay
2 (lays
4 days
I c (lays
()-meG N7-meG
(jcmol/mol guianine)
46-7
70 5
52-1
26-3
31-6
55-6
611-7
673-3
749-4
555-7
518-2
615-9
(l/miTl/ cl/mil/
06/N7 1cmol A* ,umol G*
0-076
0-104
0 070
0 047
0-061
(0090
7-0
13-6
14-3
9-4
28-6
7-7
8-9
8-8
15-2
13 9
:340
32)
* Values corrected as in Table I.
lenged with DMN at different times from
6 h to 35 days later (Table II). The repair
response elicited by this single dose of
mycotoxin occurred between 12 and 24 h
after pretreatment, and persisted at a
similar level for at least 5 days. After this
the response was more variable, but the
ratio of 06-methylguanine to 7-methyl-
guanine was consistently below that for
the control rats even 35 days later. The
control animals for the experiment, how-
ever, had a ratio of methylguanines that
was rather higher than in other studies
involving treatment with DMN at 2 mg/kg.
This effect could be due to the injection
of gum acacia. However, irrespective of
these changes in control values it is evident
that the enhanced response can persist
for several weeks after a single dose of
AFB1, though there may be more indi-
vidual variation later.
The timing of histological changes in
the livers of the AFB1-pretreated animals,
in comparison with the normal histology
seen in the gum acacia controls, is as
follows. From 12 h until Day 15 some
degeneration was present, but by Day
21 and later this effect decreased. Necroses
were obvious from 2 until 10 days, when
they too began to decline. Proliferation of
liver cells was not noticeable until Day 5,
but this then persisted to a variable
degree throughout the period of observa-
tion, and bile-duct proliferation followed
a similar pattern. As seen in Table I,
changes in the extent of incorporation of
labelled 1-C fragments into DNA purines
in this experiment were also consistent
with some degree of proliferative activity
during this period.
The enhanced repair response can also
be induced by a lower dose of AFB1
(Table III), but the observed effect is
smaller, takes longer to appear and is of
shorter duration. At this lower dose there
was little sign of a proliferative response,
as judged by the extent of incorporation
from the labelled 1-C pool. Although the
livers of the pretreated animals showed
signs of slight degeneration up to the 4th
day after pretreatment, necroses were
very rare, there was no detectable pro-
liferation ofliver cells and only one animal
showed traces of bile-duct proliferation,
at Day 10 when the repair-response had
subsided.
Effects of multiple doses
A cumulative effect of low doses of
AFB1 was also noted. Four consecutive
daily doses of 0 5 mg/kg elicited a repair
response (ratio of methylguanines 0.041)
similar to that produced by a single dose
of 2 mg/kg (Tables I and II) when the
animals were challenged with labelled
DMN (2 mg/kg) 24 h after the last dose of
AFB1. On the other hand, 8 consecutive
daily doses of AFB1 (0-25 mg/kgeach) pro-
duced only an equivocal response when the
animals were challenged on the 9th day.
DISCUSSION
So far reports indicate that once the
repair of 06-alkylguanine has been en-
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hanced, the response can persist for pro-
longed periods as the treatment is con-
tinued in the cases of DMN (Montesano
et al., 1979, 1980), DEN (Margison et al.,
1979) or AAF (Buckley et al., 1979;
Charlesworth et al., 1981) and we now show
that it can also persist for a week or more
after single treatments with AFB1. In
livers in which this response is induced the
repair capacity appears to be present in
amounts sufficient to remove 06-methyl-
guanine from DNA more efficiently than in
the controls. However, in all the earlier
reports only single challenging doses of
labelled nitrosamine were given, so there
was no indication whether the supply of
induced enzymes might be easily exhaus-
ted. In the present series of experiments
using a single dose of AFB1, administra-
tion of a low dose of unlabelled DMN
(2 mg/kg) shortly after the response had
been initiated by the mycotoxin did not
alter the response when the animals were
challenged later with labelled nitrosamine
(Table II).
It is now clear that the hepatic repair
system for 06-methylguanine can be
induced in rats by a variety of agents, i.e.
DMPT (Cooper et al., 1978), DMN (Monte-
sano et al., 1979, 1980), DEN (Margison
et al., 1979), AAF (Buckley et al., 1979)
and AFB1. These agents are hepatotoxic
to varying degrees andwillreactcovalently
with DNA after metabolism, and so
would be expected to induce some degree
of compensating regeneration. On the
basis of the histological assessment this is
indeed the case in the experiments repor-
ted here, in which proliferation of liver
cells and of bile ducts could be seen after
several days. The evidence provided by the
incorporation of 14C-labelled 1-C frag-
ments into DNA purines (Tables I, II
and III) supports this conclusion, andthere
is a tendency for the higher levels of 1-C
incorporation to correspond with the
lower ratios of 06-methylguanine to 7-
methylguanine. However, this correlation
is by no means precise, and it is not pos-
sible from the present data to decide on
the role of toxicity, DNA damage or any
other factor in inducing this response. In
practice, however, this enhanced capacity
for DNA repair may afford cell protection
in an organ which has to play a major part
in the detoxification process. In this con-
text it is ofparticular interest to note that
an "adaptive" response may occur not
only after prolonged exposure to an agent
but as early as one day after a single treat-
ment. In more general terms, this observa-
tion has wide implications not only for
exposures of an environmental nature,
but also forthoseoccurringduringtherapy.
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